Ginkgo bioworks partners with hadea in up to €24 million consortium project to deliver next-generation 'agnostic diagnostics' for respiratory viruses at the point of care

International consortium to develop rapid metagenomic ngs solutions that can identify known and novel respiratory pathogens, reduce time-to-diagnosis, and enhance hospital decision-making and public health preparedness boston , feb. 20, 2025 /prnewswire/ -- ginkgo bioworks (nyse: dna), which is building the leading platform for cell programming and biosecurity, today announced a collaboration with the european health and digital executive agency (hadea) as contracting authority under a joint tender of up to €24 million. the funding is made available through the eu4health programme, linked to the key priorities of the health emergency preparedness and response authority (hera) of the european commission.
DNA Ratings Summary
DNA Quant Ranking